Skip to main content
. 2021 May 26;53:103045. doi: 10.1016/j.msard.2021.103045

Table 2.

How respondents filled in the questionnaire.

Strongly disagree Disagree No idea Agree Strongly agree Missing
I want to get vaccinated. 6 (5.3%) 3 (2.6%) 32 (28.1%) 40 (35.1%) 32 (28.1%) 1 (0.9%)
Corona vaccination is effective in reducing the incidence of COVID-19 infection. 2 (1.8%) 2 (1.8%) 25 (21.9%) 52 (45.5%) 33 (28.9%)
Corona vaccination can cause relapse in MS patients. 8 (7%) 24 (21.1%) 71 (62.3%) 10 (8.8%) 0 1 (0.9%)
Corona vaccination can cause disease progression in MS patients. 13 (11.4%) 26 (22.8%) 67 (58.8%) 7 (6.1%) 0 1 (0.9%)
Corona vaccination could have serious side effects. 7 (6.1%) 23 (20.2%) 64 (56.1%) 18 (15.8%) 2 (1.8%)
Corona vaccination has more side effects in MS patients, compared to healthy individuals. 10 (8.8%) 14 (12.3%) 72 (63.2%) 15 (13.2%) 1 (0.9%) 2 (1.8%)
The effectiveness of corona vaccine in preventing coronary heart disease in patients with MS is similar to healthy individuals. 0 8 (7%) 48 (42.1%) 47 (41.2%) 11 (9.6%)
Corona vaccine should be a priority for MS patients. 0 1 (0.9%) 35 (30.9%) 40 (35.1%) 38 (33.3%)